Ibiayi Dagogo-Jack

12PUBLICATIONS
81CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 06, 2026
Prevalence and Actionability of MTAP Loss in Oncogene-Driven Lung Cancer.

Takashi Sakai, Zofia Piotrowska, Charlotte I Wang

|Oct 19, 2025
Updated Overall Survival Analysis From the Phase II PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer.

Melissa L Johnson, Egbert F Smit, Enriqueta Felip

|Jan 08, 2025
Treatment of Pleural Mesothelioma: ASCO Guideline Update.

Hedy L Kindler, Nofisat Ismaila, Lyudmila Bazhenova

|Nov 22, 2023
Targeted Approaches to Treatment of Pleural Mesothelioma: A Review.

Ibiayi Dagogo-Jack

|Jul 12, 2023
Integrated Radiology, Pathology, and Pharmacy Program to Accelerate Access to Osimertinib.

Ibiayi Dagogo-Jack, Amanda Manoogian, Nicholas Jessop

|Jun 04, 2023
Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With

Gregory J Riely, Egbert F Smit, Myung-Ju Ahn

Pageof 2